85
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Therapy-related Acute Myeloid Leukemia and Myelodysplasia after Successful Treatment of Acute Promyelocytic Leukemia

&
Pages 275-280 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Derek McCulloch, Christina Brown & Harry Iland. (2017) Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives. OncoTargets and Therapy 10, pages 1585-1601.
Read now
Alireza Eghtedar, Ildefonso Rodriguez, Hagop Kantarjian, Susan O'Brien, Naval Daver, Guillermo Garcia-Manero, Alessandra Ferrajoli, Tapan Kadia, Sherry Pierce, Jorge Cortes & Farhad Ravandi. (2015) Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide. Leukemia & Lymphoma 56:5, pages 1342-1345.
Read now
A. Athanasiadou, R. Saloum, I. Zorbas, A. Tsompanakou, I. Batsis, A. Fassas & A. Anagnostopoulos. (2002) Therapy-related Myelodysplastic Syndrome with Monosomy 5 and 7 Following Successful Therapy for Acute Promyelocytic Leukemia with Anthracyclines. Leukemia & Lymphoma 43:12, pages 2409-2411.
Read now

Articles from other publishers (21)

Yang Gao, Na Han, Yu JiangZiyuan Lu. (2023) Transformation from acute promyelocytic leukemia in pregnancy to acute myeloid leukemia with MLL-AF9 fusion gene: A case report and literature review. Medicine 102:48, pages e36403.
Crossref
Dawson Foster, Hari K Nair, Katherine Robbins & Nabeel Rajeh. (2023) Therapy-Related Acute Promyelocytic Leukemia: A Case Report and a Review of Literature. Cureus.
Crossref
Xue-Jiao Yin, Rong Wang, Hong-Shi Shen, Jie Jin & Hong-Hu Zhu. (2023) At What Point Are Long-Term (>5 Years) Survivors of APL Safe? A Study from the SEER Database. Cancers 15:3, pages 575.
Crossref
Abdul Muqtadir Abbasi & Usman Shaikh. (2022) Chronic myeloid leukemia developing in treated acute promyelocytic leukemia. Hematology, Transfusion and Cell Therapy 44:4, pages 602-605.
Crossref
Francesco Autore, Patrizia Chiusolo, Federica Sorà, Sabrina Giammarco, Luca Laurenti, Idanna Innocenti, Elisabetta Metafuni, Nicola Piccirillo, Livio Pagano & Simona Sica. (2021) Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience. Frontiers in Oncology 11.
Crossref
Guiying Li, Keyu Liu, Jing Zhang, Nan Wang & Yanfang Yu. (2020) Therapy-Related Pure Erythroid Leukaemia with Complex Karyotype Following Successful Treatment for Acute Promyelocytic Leukaemia. Indian Journal of Hematology and Blood Transfusion 37:2, pages 331-333.
Crossref
Tianjiao Wang, Meagan A. Jacoby, Eric J. Duncavage, Christopher A. Miller, Sharon Heath, Ramy Rahme, Pierre Fenaux, Lionel Ades, Aline Renneville, Bruno Cassinat, Akihiro Takeshita, Norio Asou, Yasushi Miyazaki, Hitoshi Kiyoi, Farhad Ravandi, Peter Westervelt, Lukas D. Wartman & John S. Welch. (2018) Exome analysis of treatment‐related AML after APL suggests secondary evolution . British Journal of Haematology 185:5, pages 984-987.
Crossref
Harry Iland. 2018. Acute Promyelocytic Leukemia. Acute Promyelocytic Leukemia 113 132 .
Fang Huang, Jun Chang, Chao Du & Rong Tao. (2015) Chronic Myeloid Leukemia Developing After Successful Treatment of Acute Promyelocytic Leukemia. Indian Journal of Hematology and Blood Transfusion 32:S1, pages 104-107.
Crossref
Harry J. Iland, Andrew Wei & John F. Seymour. (2014) Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care. Best Practice & Research Clinical Haematology 27:1, pages 39-52.
Crossref
KONG-WANG HU, XIAO-HUA PAN, FEI-HU CHEN, RONG QIN, LI-MING WU, HUA-GANG ZHU, FAN-RONG WU, JIN-FANG GE, WEN-XIU HAN, CHUN-LIN YIN & HONG-JUN LI. (2014) A novel retinoic acid analog, 4-amino-2-trifluoromethyl-phenyl retinate, inhibits gastric cancer cell growth. International Journal of Molecular Medicine 33:2, pages 415-422.
Crossref
Sang Hyuk Park, Hyun-Sook Chi, Young-Uk Cho, Seongsoo Jang, Chan-Jeoung Park & Je-Hwan Lee. (2014) A Case of Therapy-Related Acute Myeloid Leukemia With a Normal Karyotype After Sustained Molecular Complete Remission of Acute Promyelocytic Leukemia. Annals of Laboratory Medicine 34:1, pages 68-70.
Crossref
Mario Ojeda‐Uribe, Anne Schneider, Isabelle Luquet, Ana Berceanu, Pascale Cornillet‐Lefebvre, Eric Jeandidier, Bruno Lioure, Lionel Ades, Laurent Mauvieux & Chantal Himberlin. (2012) Therapy‐related acute myeloid leukemia (t‐ AML ) with poor‐risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia . European Journal of Haematology 89:3, pages 267-272.
Crossref
Jun Imagawa, Yuka HaradaTakeshi ShimomuraHideo Tanaka, Yoshiko Okikawa, Hideo Hyodo, Akiro Kimura & Hironori Harada. (2010) Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemia. Blood 116:26, pages 6018-6022.
Crossref
Martin S. Tallman & Jessica K. Altman. (2008) Curative Strategies in Acute Promyelocytic Leukemia. Hematology 2008:1, pages 391-399.
Crossref
Simone Snijder, Clemens H.M. Mellink & Hans van der Lelie. (2008) Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia. Cancer Genetics and Cytogenetics 180:2, pages 149-152.
Crossref
Toshie Ogasawara, Masako Yasuyama & Kiyotaka Kawauchi. (2005) Therapy‐related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2). American Journal of Hematology 79:2, pages 136-141.
Crossref
Roger S. Riley, Michael Idowu, Alden Chesney, Shawn Zhao, John McCarty, Lawrence S. Lamb & Jonathan M. Ben‐Ezra. (2005) Hematologic aspects of myeloablative therapy and bone marrow transplantation. Journal of Clinical Laboratory Analysis 19:2, pages 47-79.
Crossref
Martin S Tallman & Jacob M Rowe. (2003) Long-term follow-up and potential for cure in acute promyelocytic leukaemia. Best Practice & Research Clinical Haematology 16:3, pages 535-543.
Crossref
I Lobe, F Rigal-Huguet, A Vekhoff, B Desablens, D Bordessoule, C Mounier, A Ferrant, M Sanz, M Fey, C Chomienne, S Chevret, L Degos & P Fenaux. (2003) Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia 17:8, pages 1600-1604.
Crossref
. (2002) Current Awareness: Pharmacoepidemiology and Drug Safety. Pharmacoepidemiology and Drug Safety 11:8, pages 727-742.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.